Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -7 of 7 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 8/1/1991


1.		Phase II Study of 5-FU/MMPR/PALA in Unresectable Adenocarcinoma of the Pancreas (Summary Last Modified 08/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				FCCC-91006 NCI-T91-0037D, T91-0037


2.		Phase I Study with 6-Methylmercaptopurine Riboside/5-Fluorouracil by Continuous Infusion for Carcinoma, Sarcoma, and Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				no age specified								NCI-W82-0478 DFCI-81044


3.		Phase I Clinical and Pharmacologic Study of MMPR, PALA, and 5-FU in Patients with Advanced Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				no age specified								NCI-W81-0256

Last Modified: 6/1/1997


4.		Phase I Combination Chemotherapy with PALA/MMPR/5-FU in Patients with Carcinoma and Sarcoma (Summary Last Modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				no age specified				NCI				DFCI-82114 NCI-T83-0929D, T83-0929

Last Modified: 6/1/1997


5.		Phase I Combination Chemotherapy with MMPR/PALA/5-FU in Patients with Advanced Cancer (Summary Last Modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				MSKCC-87121 NCI-T87-0259C, T87-0259


6.		Phase I Study of PALA/MMPR/5-FU in Patients with Advanced Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				FCCC-88967 NCI-T88-0105D, T88-0105

Last Modified: 1/1/1992


7.		Phase I Study of 5-FU with PALA/MMPR/CF in Patients with Advanced Malignancies (Summary Last Modified 01/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				FCCC-91056 NCI-T91-0165D, T91-0165

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute